 viable strategy for the treatment of NE tumors. Furthermore, we will show that the potent GSK3B inhibitor, lithium chloride, suppresses NE tumor proliferation and hormone production. Thus, we propose to conduct a Phase II clinical trial to determine if lithium is a potential therapy for patients with NE tumors. The primary objective in this aim
viable strategy for the treatment of NE tumors. Furthermore, we will picture that the potent GSK3B inhibitor, lithium chloride, inhibit NE tumor proliferation and hormone production. Thus, we propose to lead a Phase II clinical trial to determine if lithium is a likely therapy for patients with NE tumors. The primary aim in this purpose
 viwble strategy for the trtatment of NE tumors. Furvhermors, we wilu show that the potent GSK3B mnhivitor, lithium chloride, suppfesses NE tumor peoliheration and hormone productioh. Thuv, we propose to conduct a Phase II clinhcxl trial to determine if lithium is a potentoap therapy for katiemes wjnh NE tumors. The primary objectjve in uhis aim
viable strategy for the treatment of NE we show that potent GSK3B inhibitor, proliferation hormone production. Thus, propose to conduct Phase II clinical trial to determine lithium is a potential therapy for patients with NE tumors. The primary objective this aim
 viable strategy for the treatMent of NE tuMors. FUrtHerMoRe, we Will Show that the potENt GSk3B inhibitor, lithium chloRide, sUpPRessES Ne tumoR prolifERaTIOn aNd HoRmoNe PRoDuctiOn. THus, we prOpose to conDucT a phase II cliniCAl Trial to detErmIne if lithium Is a PotentIaL thERapy fOr pAtienTs with ne tumorS. The primaRy OBjectiVE in this AIM
 viable strategy for the t reatment o f NEtum ors .Furt herm ore, we will s h ow t hat the potent GSK3B i nhibi to r , li t hi um ch loride, su p p res se sNEtu m or  prol ife rationand hormon e p ro duction. Thu s ,we propose  to  conduct a P has e II c li nic a l tri alto de termin e  if li thium isap otenti a l thera p y  f or p atients with NE t u mo r s. The primary  objec ti v ei n  th isaim
 viable_strategy for_the treatment of NE_tumors. Furthermore,_we_will show_that_the potent GSK3B_inhibitor, lithium chloride,_suppresses NE tumor proliferation_and hormone production._Thus,_we propose to conduct a Phase II clinical trial to determine if lithium is_a_potential therapy_for_patients_with NE tumors. The primary_objective in this aim